This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
Journal of Medical Case Reports Open Access 10 May 2018
-
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
Journal of Medical Case Reports Open Access 18 February 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moreau, P., Huynh, A., Facon, T. et al. Lack of efficacy of clarithromycin in advanced multiple myeloma. Leukemia 13, 490–491 (1999). https://doi.org/10.1038/sj.leu.2401332
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401332
This article is cited by
-
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
Journal of Medical Case Reports (2018)
-
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
Journal of Medical Case Reports (2018)